A PLASMIC score of 6 (indicating a 72% probability of ADAMTS13 deficiency) prompted ADAMTS13 level testing, revealing levels <5% with the presence of an inhibitor, confirming TTP diagnosis. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.